Back to calendar
Avalo Therapeutics, Inc. (AVTX) Earnings
AVTX reports earnings on Thursday, November 5, 2026
earnings report
November 5, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.56
Actual EPS: $-0.83
EPS surprise: -42.43%
Company overview
Market Cap$1.1B
PriceUSD 19.59
EPS (TTM)-4.74
52-week high24.27
52-week low8.65
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees33